Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Jefferis

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|August 31, 2007
Antibody therapeutics: isotype and glycoform selectionRoy Jefferis
Archives of Biochemistry and Biophysics|April 3, 2012
Isotype and glycoform selection for antibody therapeuticsRoy Jefferis
British Journal of Hospital Medicine (London, England : 2005)|August 8, 2017
Biologics: structural heterogeneity and immunogenicityRoy Jefferis
Immunology Letters|May 15, 2002
Interaction sites on human IgG-Fc for FcgammaR: current modelsRoy Jefferis, John Lund
Nature Biotechnology|October 13, 2006
Post-translational modifications in the context of therapeutic proteinsGary Walsh, Roy Jefferis
Mabs|January 16, 2010
Human immunoglobulin allotypes: possible implications for immunogenicityRoy Jefferis, Marie-Paule Lefranc
Molecular Immunology|June 24, 2014
Crystal structure of deglycosylated human IgG4-FcAnna M Davies, Roy Jefferis, Brian J Sutton
Trends in Biotechnology|September 20, 2005
Biopharmaceutical production in plants: problems, solutions and opportunitiesVéronique Gomord, Paul Chamberlain, Roy Jefferis, et al.
Experientia Supplementum (2012)|October 23, 2021
Importance and Monitoring of Therapeutic Immunoglobulin G GlycosylationYusuke Mimura, Radka Saldova, Yuka Mimura-Kimura, et al.
Experientia Supplementum (2012)|October 23, 2021
Micro-Heterogeneity of Antibody MoleculesYusuke Mimura, Radka Saldova, Yuka Mimura-Kimura, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|August 31, 2007
Antibody therapeutics: isotype and glycoform selectionRoy Jefferis
Archives of Biochemistry and Biophysics|April 3, 2012
Isotype and glycoform selection for antibody therapeuticsRoy Jefferis
British Journal of Hospital Medicine (London, England : 2005)|August 8, 2017
Biologics: structural heterogeneity and immunogenicityRoy Jefferis
Immunology Letters|May 15, 2002
Interaction sites on human IgG-Fc for FcgammaR: current modelsRoy Jefferis, John Lund
Nature Biotechnology|October 13, 2006
Post-translational modifications in the context of therapeutic proteinsGary Walsh, Roy Jefferis
Mabs|January 16, 2010
Human immunoglobulin allotypes: possible implications for immunogenicityRoy Jefferis, Marie-Paule Lefranc
Molecular Immunology|June 24, 2014
Crystal structure of deglycosylated human IgG4-FcAnna M Davies, Roy Jefferis, Brian J Sutton
Trends in Biotechnology|September 20, 2005
Biopharmaceutical production in plants: problems, solutions and opportunitiesVéronique Gomord, Paul Chamberlain, Roy Jefferis, et al.
Experientia Supplementum (2012)|October 23, 2021
Importance and Monitoring of Therapeutic Immunoglobulin G GlycosylationYusuke Mimura, Radka Saldova, Yuka Mimura-Kimura, et al.
Experientia Supplementum (2012)|October 23, 2021
Micro-Heterogeneity of Antibody MoleculesYusuke Mimura, Radka Saldova, Yuka Mimura-Kimura, et al.
Pageof 4